Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Covetrus, Inc.    CVET

COVETRUS, INC.

(CVET)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
02/14/2020 02/18/2020 02/19/2020 02/20/2020 02/21/2020 Date
12.73(c) 12.94(c) 12.95(c) 12.53(c) 12(c) Last
837 568 1 496 503 2 743 567 995 028 1 625 671 Volume
-2.60% +1.65% +0.08% -3.24% -4.23% Change
More quotes
Financials (USD)
Sales 2019 3 966 M
EBIT 2019 159 M
Net income 2019 -644 M
Debt 2019 1 069 M
Yield 2019 -
Sales 2020 4 135 M
EBIT 2020 167 M
Net income 2020 11,1 M
Debt 2020 916 M
Yield 2020 -
P/E ratio 2019 -1,40x
P/E ratio 2020 78,3x
EV / Sales2019 0,61x
EV / Sales2020 0,55x
Capitalization 1 345 M
More Financials
Company
More about the company
Surperformance© ratings of Covetrus, Inc.
Trading Rating : Investor Rating :
More Ratings
Latest news on COVETRUS, INC.
02/20COVETRUS : Change in Directors or Principal Officers (form 8-K/A)
AQ
02/11SHAREHOLDER ALERT : Robbins LLP Reminds Investors Covetrus, Inc. (CVET) Sued for..
BU
01/21COVETRUS, INC. : Change in Directors or Principal Officers (form 8-K)
AQ
01/21COVETRUS : Change in Directors or Principal Officers (form 8-K/A)
AQ
01/16COVETRUS : Launches New Platform Application to Drive Proactive Prescription Man..
BU
01/14COVETRUS, INC. : Regulation FD Disclosure (form 8-K)
AQ
01/14COVETRUS : Enters Into Definitive Agreement to Divest scil animal care to Heska
BU
01/14HESKA CORPORATION : to Acquire scil animal care, a European Leader in Veterinary..
PR
01/07COVETRUS : Announces Changes to Senior Management Team
BU
01/03COVETRUS : to Present at the J.P. Morgan 38th Annual Healthcare Conference
BU
2019COVETRUS, INC. : Change in Directors or Principal Officers, Financial Statements..
AQ
2019COVETRUS : Announces Leadership Changes, Reaffirms 2019 Financial Guidance
BU
2019FRIDAY DEADLINE ALERT : The Schall Law Firm Announces it is Investigating Claims..
BU
2019COVETRUS 96 HOUR DEADLINE ALERT : Former Louisiana Attorney General and Kahn Swi..
BU
2019DEADLINE ALERT : Bragar Eagel & Squire, P.C. Reminds Investors That a Class Acti..
BU
More news
News in other languages on COVETRUS, INC.
01/14COVETRUS : schließt endgültige Vereinbarung über die Veräußerung von scil animal..
01/14COVETRUS : annonce avoir conclu un accord définitif pour vendre les activités sc..
01/07COVETRUS : meldet Veränderungen auf der Führungsebene
01/07COVETRUS : annonce des changements au sein de son équipe de direction
2019COVETRUS : meldet Führungswechsel, bestätigt Finanzprognose für 2019
More news
Analyst Recommendations on COVETRUS, INC.
More recommendations
Sector news : Medical Equipment, Supplies & Distribution - NEC
02/21Pharmaceutical companies develop system to better track counterfeit drugs
RE
02/20FISHER & PAYKEL HEALTHCARE : F&P Healthcare Raises Fiscal Year Earnings, Revenue..
DJ
02/20SMITH & NEPHEW : +Nephew forecasts sales growth after best year since 2010
RE
02/18MEDTRONIC : Raises 2020 Guidance, Sets 4Q Outlook
DJ
02/18MEDTRONIC : 3Q Profit, Sales Rise
DJ
More sector news : Medical Equipment, Supplies & Distribution - NEC
Chart COVETRUS, INC.
Duration : Period :
Covetrus, Inc. Technical Analysis Chart | CVET | US22304C1009 | MarketScreener
Technical analysis trends COVETRUS, INC.
Short TermMid-TermLong Term
TrendsBearishBullishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 8
Average target price 11,63  $
Last Close Price 12,00  $
Spread / Highest target 33,3%
Spread / Average Target -3,13%
Spread / Lowest Target -45,8%
EPS Revisions
Managers
NameTitle
Benjamin C. Wolin President, Chief Executive Officer & Director
Philip A. Laskaway Chairman
Stuart B. Gleichenhaus Chief Financial Officer
David Evans Shaw Director
Deborah G. Ellinger Director
Sector and Competitors
1st jan.Capitalization (M$)
COVETRUS, INC.-9.09%1 345
MEDTRONIC PLC0.36%151 884
BAXTER INTERNATIONAL INC.10.82%47 313
HOYA CORPORATION-0.10%34 270
ZIMMER BIOMET HOLDINGS5.15%32 373
DEXCOM, INC.33.15%26 677